MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has Fifteen API and Six finished dosage facilities established across India & USA. The group has an integrated R&D …
A pharmaceutical company specialising in streamlined formulation development and manufacturing of quality pharmaceutical products.HOF Pharmaceuticals Limited, we are sincerely dedicated to improving the health and well-being across the world by innovating and delivering high-quality pharmaceutical products. We are a leading manufacturer & exporter of Tablets, Capsules & …
Granules India Ltd. is a fully integrated pharmaceutical manufacturer. The Company manufactures Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs) which are distributed in over 55 countries. Vacancy details: Department: Production Chemist Roles (Male Candidates pereferred as we operate in shifts) Experience: 0 to …
Anthea Pharma Private Limited Walk In Interview 2024.Anthea Pharma Private Limited Notification full details below.Interested and eligible candidates can attend Interview on scheduled time and venue.Our people are the foundation of our success and our most valuable asset. Our workplace policies and programmes are created with …
Shilpa Medicare Ltd Walk-in Interview 2024.Shilpa Medicare Ltd Notification full details below.Interested and eligible candidates can attend Interview on scheduled time and venue.Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML …
Dr. Reddy€™s Laboratories Ltd. is a leading multinational pharmaceutical company based across global locations. Each of our 24,000 plus employees comes to work every day for one collective purpose: to accelerate access to affordable and innovative medicines because Good Health Can€™t Wait.We started in 1984 with …
Zydus Lifesciences Ltd. on Tuesday announced its unaudited consolidated financial results for the quarter and half year ended September 30th, 2024. The company’s net profit for the July to September period surged 13.7% year-on-year to Rs. 911 crore, compared to Rs. 801 crore reported in the same …
Ad Blocker Detected
Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.
error: Content is protected !!
